Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
MedTech
Boston Scientific to drop $533M to acquire Nalu Medical
Boston Scientific shelled out $533 million to buy Nalu Medical, which produces a miniaturized neurostimulation implant aimed at treating chronic pain.
Joseph Keenan
Oct 20, 2025 12:04pm
Xoma and Lava buyout cools with lower offer
Oct 17, 2025 2:35pm
Fierce Pharma
Halozyme CEO targets new deals as IRA uncertainty subsides
Oct 14, 2025 9:40am
J&J eyes takeover of immunology partner Protagonist: WSJ
Oct 10, 2025 2:30pm
89bio was left between a Roche and a hard place in buyout talks
Oct 2, 2025 9:55am
Novo vs. KBP Chapter 3: Fraud or due diligence slipup?
Oct 2, 2025 3:00am